IP Library › Granted Patent US 12,185,747
Granted Patent B2
US 12,185,747 · App. 16/863,418 · Granted Jan 7, 2025

Fasting-mimicking diet (FMD) as an intervention for Alzheimer's disease (AD)

Inventors: Valter D. Longo (Playa del Rey, CA); Min Wei (West Covina, CA); Priya Rangan (Los Angeles, CA)
Assignee: University of Southern California
A23L33/20A23L33/30A23L33/40A61K9/0053A61K47/26A61K47/42A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,185,747
App. No.
16/863,418
Granted
Jan 7, 2025
Kind
B2
Abstract

A method of treating Alzheimer's associated pathology includes a step of identifying subject having a pathology that is associated with Alzheimer's disease. A fasting mimicking diet (FMD) is then administered to the subject for a first time period. Methods for treating amyloid plaque formation and/or elevated levels of tau protein as well as neuroinflammation are also provided.

Claims (17)

1. A method of treating Alzheimer's disorders associated with APOE4 apolipoprotein expression comprising:

a) identifying a subject having an Alzheimer's disorder associated with APOE4 apolipoprotein expression; and

b) administering a fasting mimicking diet (FMD) to the subject for a first time period, wherein the FMD provides 2.47 kcal/g plus or minus 30 percent on day 1 and 1.63 kcal/g plus or minus 30 percent on day 2, wherein the FMD is administered for only 1 day with a frequency of at least 1 day/week every week of a month or wherein the FMD will substitute a subject's normal diet for a period of 2 days every week.

2. The method of claim 1 wherein the Alzheimer's disorder associated with APOE4 apolipoprotein expression exhibits amyloid plaque formation.

3. The method of claim 1 wherein the Alzheimer's disorder associated with APOE4 apolipoprotein expression exhibits levels of tau protein in the subject.

4. The method of claim 1 wherein the fasting mimicking diet is administered for a period of 4 to 10 days every 2-12 weeks.

5. The method of claim 1 wherein step b) is repeated a plurality of times at predetermined intervals.

6. The method of claim 5 wherein step b) is repeated at intervals from one week to 6 months.

7. The method of claim 5 wherein the subject is administered a normal diet in between repetition of step b).

8. The method of claim 1 wherein the FMD provides 4.5-7 kcal per pound of body weight (or 10-16 kcal per kilogram body weight).

9. The method of claim 1 wherein on day 1, the FMD provides less than 30 grams of sugar, less than 28 grams of protein, 20-30 grams of monounsaturated fats, 6-10 grams of polyunsaturated fats and 2-12 grams of saturated fats.

10. The method of claim 9 wherein on days 2-5 the FMD provides less than 20 grams of sugar, less than 18 grams of protein, 10-15 grams of monounsaturated fats, 3-5 grams of polyunsaturated fats and 1-6 grams of saturated fats.

11. The method of claim 10 wherein the FMD also provides micronutrients at greater than 25% of the recommended Daily Value (DV).

12. The method of claim 1 wherein the FMD provides 3-5 kcal per pound of body weight.

13. The method of claim 12 wherein the day 1 FMD diet contains less than 30 grams of sugar, less than 28 grams of protein, 20-30 grams of monounsaturated fats, 6-10 grams of polyunsaturated fats and 2-12 grams of saturated fats.

14. The method of claim 13 wherein the day 2 FMD diet includes less than 20 grams of sugar, less than 18 grams of protein, 10-15 grams of monounsaturated fats, 3-5 grams of polyunsaturated fats and 1-6 grams of saturated fats.

15. The method of claim 13 wherein the step of administering the fasting mimicking diet includes administering a diet package that provides caloric, food and nutritional specification, and administration schedule of the fasting mimicking diet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2020
From: LONGO, VALTER D.; WEI, MIN; RANGAN, PRIYA
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 053170/0885 →
Continuity (2)
Provisional Application 62840762 · Apr 30, 2019
Related Publication 20200345053A1 · Nov 5, 2020
References Cited (41)
US 8211700B2 · Longo · 2012 [cited by applicant]
US 8728815B2 · Longo · 2014 [cited by applicant]
US 8865646B2 · Longo · 2014 [cited by applicant]
US 9237761B2 · Longo et al. · 2016 [cited by applicant]
US 9386790B2 · Longo et al. · 2016 [cited by applicant]
US 10015980B2 · Longo et al. · 2018 [cited by applicant]
US 10172839B2 · Longo et al. · 2019 [cited by applicant]
US 10433576B2 · Longo et al. · 2019 [cited by applicant]
US 20110118528A1 · Longo et al. · 2011 [cited by applicant]
US 20140227373A1 · Longo et al. · 2014 [cited by applicant]
US 20140328863A1 · Longo · 2014 [cited by applicant]
US 20150133370A1 · Longo · 2015 [cited by applicant]
US 20160303056A1 · Longo et al. · 2016 [cited by applicant]
US 20160306920A1 · Soon-Shiong · 2016 [cited by applicant]
US 20160324193A1 · Longo et al. · 2016 [cited by applicant]
US 20160331016A1 · Longo et al. · 2016 [cited by applicant]
US 20170027217A1 · Longo et al. · 2017 [cited by applicant]
US 20170035093A1 · Longo et al. · 2017 [cited by applicant]
US 20170035094A1 · Longo et al. · 2017 [cited by applicant]
US 20170232053A1 · Longo et al. · 2017 [cited by applicant]
US 20170185727A1 · Harris et al. · 2017 [cited by applicant]
US 20170325493A1 · Longo et al. · 2017 [cited by applicant]
US 20180228198A1 · Brandhorst et al. · 2018 [cited by applicant]
US 20180301220A1 · Rothman · 2018 [cited by applicant]
US 20190029301A1 · Longo et al. · 2019 [cited by applicant]
US 20200029614A1 · Longo et al. · 2020 [cited by applicant]
KR 20080079707 · 2008 [cited by applicant]
WO 2011050302A2 · 2011 [cited by applicant]
WO 2016179466A1 · 2016 [cited by applicant]
WO 2018138090 · 2018 [cited by examiner]
Medical Articles by Dr Ray, Fast Mimicking Diet, Dec. 30, 2017, accessed at https://www.askdrray.com/fasting-mimicking-diet/. [cited by examiner]
Bloom, G.S., “Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis,” JAMA Neurology, v. 71, n. 4, 2014, pp. 505-508. [cited by applicant]
Brandhorst, S. et al., “A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan,” Cell Metabolism 22, 2015, pp. 86-99. [cited by applicant]
Elder, G.A. et al., “Transgenic Mouse Models of Alzheimer's Disease,” Mt. Sinai J. Med., 77(1), 2010, pp. 69-81. [cited by applicant]
Liu, C-C et al., “Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy,” Nat Rev Neurol. 2013; 9(2), pp. 106-118. [cited by applicant]
Parrella, E. et al., “Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model,” Aging Cell (2013), 12, pp. 257-268. [cited by applicant]
Wei, M. et al., “Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease,” Sci Transl Med 2017; 9(377), pp. 1-25. [cited by applicant]
Youmans, K.L. et al., “APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease,” The J. of Biological Chemistry, v. 287, n. 50, 2012, pp. 41774-41786. [cited by applicant]
Wei, M. et al., “Fasting-Mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease,” Sci. Transl. Med. 9, Feb. 15, 2017, 12 pgs. [cited by applicant]
International Search Report dated Aug. 21, 2020 for PCT Appn. No. PCT/US2020/030793 filed Apr. 30, 2020, 3 pgs. [cited by applicant]
Search Report & Written Opinion dated Dec. 21, 2022 for European Appn. No. 20798070.7, 7 pgs. [cited by applicant]